Literature DB >> 2229374

Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

B R Dannemann1, W C Vaughan, P Thulliez, J S Remington.   

Abstract

We evaluated the recently described differential agglutination test (HS/AC test) to differentiate recently acquired toxoplasma infections from those acquired in the more distant past in sera obtained from 38 patients with carefully defined symptomatic and asymptomatic infections. AC antigens detect acute-phase-specific immunoglobulin G (IgG) antibodies against Toxoplasma gondii tachyzoites that are formed only during the acute stage of infection in humans. The HS/AC test correctly identified recently acquired infections in patients with toxoplasmic lymphadenopathy or asymptomatic infections (including infections in 7 women who seroconverted during gestation) in 31 of 33 patients. We also studied 15 individuals who had been infected for at least 2 years. In that group, only 13% had an acute pattern in the HS/AC test. However, the wide range in times from infection (from 2 to 14 years) did not allow for an estimate of when the pattern in the HS/AC test changed from acute to not acute. These results reveal that in the appropriate clinical situation, when both IgG and IgM tests are positive and a question still remains about the acuteness of infection, the HS/AC test may be useful for differentiating between toxoplasma infections acquired recently and those acquired in the more distant past.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229374      PMCID: PMC268080          DOI: 10.1128/jcm.28.9.1928-1933.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

Authors:  F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; C Aufrant; D Valenti; W L Cox
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

2.  Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis.

Authors:  R F Dorfman; J S Remington
Journal:  N Engl J Med       Date:  1973-10-25       Impact factor: 91.245

3.  Prenatal diagnosis of congenital toxoplasmosis.

Authors:  G Desmonts; F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; M Chartier
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

4.  Comparison of methods for quantitating antigen-specific immunoglobulin M antibody with a reverse enzyme-linked immunosorbent assay.

Authors:  J P Siegel; J S Remington
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

5.  Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity.

Authors:  G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

6.  Role of serology in the diagnosis of toxoplasmic lymphadenopathy.

Authors:  R G Brooks; R E McCabe; J S Remington
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

7.  [A new agglutination reaction for the diagnosis of the developmental stage of acquired toxoplasmosis].

Authors:  P Thulliez; J S Remington; F Santoro; G Ovlaque; S Sharma; G Desmonts
Journal:  Pathol Biol (Paris)       Date:  1986-03

8.  Serological and immunochemical characterization of monoclonal antibodies to Toxoplasma gondii.

Authors:  E Handman; J S Remington
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

9.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

10.  Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.

Authors:  P Hohlfeld; F Daffos; P Thulliez; C Aufrant; J Couvreur; J MacAleese; D Descombey; F Forestier
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

View more
  36 in total

1.  VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Authors:  Jose G Montoya; Oliver Liesenfeld; Sandra Kinney; Cynthia Press; Jack S Remington
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Common questions about the diagnosis and management of congenital toxoplasmosis.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-03       Impact factor: 2.253

5.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

6.  Bicentric evaluation of Access Toxo immunoglobulin M (IgM) and IgG assays and IMx toxo IgM and IgG assays and comparison with Platelia Toxo IgM and IgG assays.

Authors:  A Decoster; B Lecolier
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

7.  Expression, characterization, and serologic reactivity of recombinant surface antigen P22 of Toxoplasma gondii.

Authors:  S F Parmley; G D Sgarlato; J Mark; J B Prince; J S Remington
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

8.  Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults.

Authors:  Cynthia Press; Jose G Montoya; Jack S Remington
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

9.  Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.

Authors:  V Meroni; F Genco; C Tinelli; P Lanzarini; L Bollani; M Stronati; E Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

10.  Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy.

Authors:  Jose G Montoya; Heather B Huffman; J S Remington
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.